MedPath

Effect of kasni seeds (A unani drug) on obesity related disorders.

Phase 2
Completed
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2015/12/006435
Lead Sponsor
Jamia Hamdard University Hamdard Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

a)Metabolic syndrome, otherwise healthy subject (BMI >25)

b)Patient groups-T2 DM cases, metabolic syndrome with CAD

Exclusion Criteria

1.Type 1 diabetes cases

2.All critically ill patients, renal failure.

3.Cirrhosis liver, jaundice, cancers

4.Patients on estrogen, corticosteroid,

valproate)

5.Alcohol addicts.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath